Inventor · disambiguated record
Jose-Alain Sahel
Also filed as: SAHEL JOSE · SAHEL JOSE-ALAIN · SAHEL JOSÉ-ALAIN · SAHEL José
46 granted patents·53 pending applications·128 citations·filing 1999–2025
97Inventor score
Files withINST NAT SANTE RECH MED26UNIV SORBONNE13LEVEILLARD THIERRY7UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION5BIOPHYTIS4
Top patents by PatentIndex Score
99 records- 0193US8518695B2Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2LEVEILLARD THIERRY·Filed 2012·Granted Aug 27, 2013·13 cites·16 claims
- 0293US8394756B2Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cellsLEVEILLARD THIERRY·Filed 2012·Granted Mar 12, 2013·14 cites·10 claims
- 0393US8114849B2Retinal dystrophy-associated protein and uses thereofLEVEILLARD THIERRY·Filed 2007·Granted Feb 14, 2012·15 cites·6 claims
- 0490US8071745B2Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the sameLEVEILLARD THIERRY·Filed 2007·Granted Dec 6, 2011·14 cites·8 claims
- 0588US8957043B2Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2NOVARTIS AG·Filed 2013·Granted Feb 17, 2015·4 cites·15 claims
- 0684US7795387B2Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVFNOVARTIS AG·Filed 2002·Granted Sep 14, 2010·13 cites·7 claims
- 0782US9575075B2Methods for treating cone dystrophy with neuronal viability factor, RDCVF2LEVEILLARD THIERRY·Filed 2008·Granted Feb 21, 2017·2 cites·1 claims
- 0881US2024093229A1Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2023·Application pending·0 cites
- 0980US8779093B2Neuronal viability factor and use thereofLEVEILLARD THIERRY·Filed 2009·Granted Jul 15, 2014·5 cites·5 claims
- 1080US8193153B2Trophic factor for the treatment of retinal degenerative diseasesLEVEILLARD THIERRY·Filed 2008·Granted Jun 5, 2012·5 cites·7 claims
- 1179US9353162B2Disease-associated proteinsNOVARTIS AG·Filed 2012·Granted May 31, 2016·3 cites·5 claims
- 1279US2025059563A1Constructs comprising neuronal viability factors and uses thereofSPARINGVISION·Filed 2024·Application pending·0 cites
- 1378US10668129B2Synergistic combination of neuronal viability factors and uses thereofINST NAT SANTE RECH MED·Filed 2016·Granted Jun 2, 2020·2 cites·5 claims
- 1478US2023220414A1Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1577US10004780B2Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)INST NAT SANTE RECH MED·Filed 2013·Granted Jun 26, 2018·2 cites·6 claims
- 1676US11428698B2Neuronal viability factor and use thereof in Alzheimer's diseaseINST NAT SANTE RECH MED·Filed 2019·Granted Aug 30, 2022·1 cites·2 claims
- 1776US2022389446A1Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1875US2022404376A1Neuronal viability factor and use thereofINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1974US9994815B2Methods for obtaining retinal progenitors, retinal pigmented epithelial cells and neural retinal cellsUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2014·Granted Jun 12, 2018·3 cites·18 claims
- 2074US9017999B2Importation of mitochondrial protein by an enhanced allotopic approachCORRAL-DEBRINSKI MARISOL·Filed 2006·Granted Apr 28, 2015·4 cites·8 claims
- 2173US11723988B2Methods of expressing a polynucleotide of interest in the cone photoreceptors of a subject comprising the subretinal delivery of a therapeutically effective amount of a recombinant AAV9-derived vectorINST NAT SANTE RECH MED·Filed 2018·Granted Aug 15, 2023·1 cites·7 claims
- 2273US11702671B2Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2021·Granted Jul 18, 2023·0 cites·13 claims
- 2369US2019064189A1Neuronal viability factor and use thereofINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 2468US2020277623A1Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 2566US9962540B2Biocompatible carbon based electrode and its preparation processUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2013·Granted May 8, 2018·7 cites·20 claims
- 2665US10513503B2Use of 3-deoxyanthocyanidins for treating occular diseasesBIOPHYTIS·Filed 2016·Granted Dec 24, 2019·1 cites·7 claims
- 2764US10519232B2Agents for use in the treatment of retinal inflammationUNIV SORBONNE·Filed 2015·Granted Dec 31, 2019·1 cites·8 claims
- 2863US12491263B2Polymer-based implant for retinal therapy and methods of making and using the sameUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2020·Granted Dec 9, 2025·0 cites·17 claims
- 2963US2024165198A1Optogenetic visual restoration using chrimsonGENSIGHT BIOLOGICS SA·Filed 2023·Application pending·0 cites
- 3062US2022040333A1Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency diseaseSANOFI SA·Filed 2021·Application pending·0 cites
- 3161US2018355372A1Importation of mitochondrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 3261US2025042983A1Anti-lcn-2 antibodies as a treatment for eye disordersUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 3360US9987167B2Method and device for controlling a device for aiding visionLORACH HENRI·Filed 2012·Granted Jun 5, 2018·4 cites·19 claims
- 3460US2015087054A1Importation of mitochodrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 3560US2014377869A1Importation of mitochodrial protein by an enhanced allotopic approachINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 3660US2017014478A1Neuronal viability factor and use thereofINST NAT DE LA SANTE ET DE LAS RECH MEDICALE·Filed 2016·Application pending·0 cites
- 3759US2015038557A1Methods and compositions for treatment of retinal degenerative diseasesINST NAT SANTE RECH MED·Filed 2013·Application pending·0 cites
- 3858US10955654B2Imaging device and methodUNIV PIERRE ET MARIE CURIE PARIS 6·Filed 2015·Granted Mar 23, 2021·1 cites·10 claims
- 3958US2020318138A1Constructs comprising neuronal viability factors and uses thereofSPARINGVISION·Filed 2018·Application pending·0 cites
- 4056US10857239B2Methods for the treatment and diagnosis of Alzheimer's disease and traumatic brain injuriesINST NAT SANTE RECH MED·Filed 2016·Granted Dec 8, 2020·0 cites·8 claims
- 4156US9715837B2Text reading and translation in a visual prosthesisSECOND SIGHT MEDICAL PRODUCTS INC·Filed 2012·Granted Jul 25, 2017·0 cites·9 claims
- 4256US2025017769A1Polymer-based gel implant for retinal therapy and methods of making and using the sameUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 4356US2021069346A1Methods for the Treatment and Diagnosis of Alzheimer's Disease and Traumatic Brain InjuriesINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 4455US2023089949A1Small molecules for treating age-related retinal diseasesUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 4555US2021308169A1Methods and compositions for treatment of retinal degenerative diseasesINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 4654US8774938B2Implant having three-dimensional shape for electrically stimulating a nerve structureLORACH HENRI·Filed 2011·Granted Jul 8, 2014·2 cites·31 claims
- 4754US2023172919A1An insulin sensitizer for use in the prevention and/or treatment of the damages caused by retinal detachmentUNIV SORBONNE·Filed 2021·Application pending·0 cites
- 4854US2024197913A1Compositions and methods for treating retinal degenerative disordersINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 4954US2016213701A1Methods and compositions for treatment of retinal degenerative diseasesINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2016·Application pending·0 cites
- 5053US12497591B2Compositions and methods for efficient amplification of retinal progenitors cellsUNIV SORBONNE·Filed 2019·Granted Dec 16, 2025·0 cites·15 claims
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jose-Alain Sahel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →